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Hepatic Hemangiomas: Spectrum of 
US Appearances on Gray-scale, Power
Doppler, and Contrast-Enhanced US
Because US plays a key role in the initial evaluation of hepatic hemangiomas,
knowledge of the entire spectrum of US appearances of these tumors is impor-
tant. Most hemangiomas have a distinctive US appearance, and even with those
with atypical appearances on conventional gray-scale US, specific diagnoses can
be made using pulse-inversion harmonic US with contrast agents. In this essay,
we review the spectrum of US appearances of hepatic hemangiomas on conven-
tional gray-scale, power Doppler, and pulse-inversion harmonic US with contrast
agents.
avernous hemangiomas are the most common benign tumor of the liver,
and are not infrequently encountered incidentally during US screening.
Because the vast majority of hepatic hemangiomas are asymptomatic and
require no treatment, they must be differentiated from hepatic malignancies. Most
have a distinctive US appearance (1 4) but some, known as atypical hemangiomas,
show various US patterns (5 8). For the differentiation of the atypical variety, dynamic
contrast-enhanced studies have been widely employed. Using microbubble contrast
agents, it has been shown that pulse-inversion harmonic US can effectively depict the
typical enhancement patterns of hepatic hemangiomas (9), enabling specific diagnosis.
In this essay, we review the spectrum of US appearances of these hemangiomas as
seen on conventional gray-scale, power Doppler, and pulse-inversion harmonic US
with contrast agents.
Conventional Gray-Scale US
The most common and generally accepted  typical US features of hepatic heman-
giomas are their small size, uniform hyperechogenicity, well-defined margin, and pos-
terior echo enhancement (1 3) (Fig. 1). In addition, follow-up scanning only rarely
shows a change in size, appearance, or detectability (4). Their distinctive appearances
at US are considered to be due to histological characteristics. They are usually com-
posed of large blood-filled cavernous spaces, lined by a single layer of flat endothelial
cells and separated by fibrous septa; multiple interfaces between the walls of the sinus-
es and the blood within them account for the typical hyperechogenicity seen at US (4).
The enhanced through-transmission observed in many cases reflects the low acoustic
impedance of blood-filled spaces and tends to occur in hemangiomas larger than 25
mm (2).
Because hemangiomas may undergo various changes including internal hemorrhage
with necrosis, thrombosis, myxomatous change, fibrosis, and- rarely- calcification as
they become larger (1, 4),  atypical US features are frequently seen in larger ones.
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CUnlike a typical hemangioma, one that is atypical has an
internal echo pattern at least partially hypoechoic; a hyper-
echoic mass with a hypoechoic central portion or de-
creased echogenicity can be seen throughout the entire le-
sion (Figs. 2 7). The most suggestive US feature of this type
of hemangioma is an echogenic border, seen as a thick
echogenic rind or thin rim around a tumor (4) (Figs. 2 and
6). Although the prevalence of atypical hemangioma has
not been precisely determined, it seems that approximately
20 40% of hemangiomas are of this kind (4, 5).
The echogenicity of hepatic parenchyma influences the
US appearance of a hemangioma. Because of the increased
echogenicity of attenuating fatty liver parenchyma, diffuse
fatty infiltration may lead to an atypical echo-poor appear-
ance (6) (Fig. 8). If a  typical hemangioma is present in a
liver in which fatty infiltration has occurred, its US appear-
ance will be altered. The lesion will initially appear less hy-
perechoic than isoechoic, and finally hypoechoic relative to
infiltrated liver. Fatty infiltration of the liver may also
cause obscuration of the echogenic border around the tu-
mor (5).
It has recently been shown that the speed of contrast en-
hancement occurring during incremental dynamic CT or
multiphase dynamic MR imaging provides a basis for pre-
dicting the echo pattern at US, and vice versa. On dynamic
CT or MR images, sonographically hypoechoic heman-
giomas tend to show rapid enhancement, but if hypere-
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Fig. 3. A 42-year-old man with a hepatic hemangioma in the right
lobe. Oblique sagittal US shows a well-defined hyperechoic le-
sion with a hypoechoic central portion.
Fig. 4. A 60-year-old woman with a hepatic hemangioma in the
left lobe. Transverse US demonstrates contour bulging; the mass
is subtly hypoechoic (arrows) relative to normal liver parenchyma
and lacks an echogenic border.
Fig. 1. A 36-year-old man with a hepatic hemangioma showing
typical US features including uniform hyperechogenicity, well-de-
fined margins and posterior sonic enhancement (arrows). 
Fig. 2. A 46-year-old man with a hepatic hemangioma in the right
lobe. Transverse US shows a well-defined large mass of hetero-
geneous echogenecity with hypoechoic foci. A thin echogenic rim
seen around the tumor (arrowheads) suggests hepatic heman-
gioma.choic, they tend to enhance slowly (7, 8) (Figs. 9 and 10).
Power Doppler US
As techniques for evaluating the vascularity of various
organs and diseases, color and power Doppler US have re-
cently shown promise. Since power Doppler US is superior
to color Doppler US in detecting slow flow, it has been
used in atempts to diagnose hepatic hemangiomas specifi-
cally on the basis of their typical hemodynamic features.
Though it was initially believed  that power Doppler is
able to depict slow flow within hemangiomas (10), it has
been suggested that homogeneous noise from highly reflec-
tive interfaces can be misinterpreted as true flow (11). To
avoid these false signals, power Doppler parameters must
therefore be optimized. A recent study in which a Doppler
phantom/flow control system and a 2 4 MHz transducer
were used found that for determining the vascularity of hy-
perechoic tissue, a pulse repetition frequency of 1,000 Hz
and a medium wall filter were adequate. Using these opti-
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Fig. 5. A 66-year-old man with a diffuse hemangioma in the right lobe. 
A. Transverse US shows a large heterogeneous mass (arrows). The major portion of the lesion shows hyperechogenicity, especially in
the periphery, and within it scattered hypoechoic foci are noted (arrowheads). Although the lesion abuts the right portal vein, there is no
evidence of invasion of this vessel.
B. Celiac angiogram shows diffuse enhancement with scattered foci of contrast material puddling.
AB
Fig. 6. A 49-year-old man with a hepatic hemangioma in the left
lobe. Sagittal US shows a small isoechoic mass detectable only
by its echogenic border (arrows) and subtle contour bulging. 
Fig. 7. A 34-year-old woman with an exophytic hepatic heman-
gioma in the caudate lobe. Transverse US shows a large square-
shaped mass surrounded by the left lobe of the liver (lv), aorta
(a), inferior vena cava (v), and right portal vein (p). The lesion
shows heterogeneous echogenicity and has a multiple internal
hypoechoic portion. mized parameters, the majority of hepatic hemangiomas
produced either no power Doppler signal or one that was
minimal (12) (Fig. 11A). 
Power Doppler US with a Contrast Agent
The majority of hepatic hemangiomas show a typical en-
hancement pattern: peripheral nodular or globular en-
hancement during the bolus dynamic phase and centripetal
fill-in and persistent enhancement during the delayed
phase, and for this reason, dynamic contrast-enhanced CT
or MR imaging has been widely used for diagnosis. Since
microbubble contrast agents for US have become avail-
able, the efficacy of these for the characterization of focal
hepatic lesions has been the subject of numerous investiga-
tions (9, 13 15). In hepatocellular carcinoma, the use of
contrast agents greatly increases intratumoral Doppler sig-
nals (13, 14), but in hemangiomas, the use of power
Doppler US with microbubble agents reveals either no in-
ternal vascularity or sparse peripheral flow (13, 15) (Fig.
11). Due to its lack of sensitivity in detecting slow flow in
hemangiomas, power Doppler US can not therefore, be
used for the specific diagnosis of hepatic hemangioma,
even with the use of microbubble agents (15).
Pulse-Inversion Harmonic US with a Contrast Agent
Pulse-inversion harmonic US is a newly introduced tech-
nique for displaying the amplitude of second harmonic sig-
nals resulting from non-linear echoes. In contrast to power
Doppler US, pulse-inversion harmonic US with interval
delay scanning can provide strong gray-scale enhancement
by microbubble contrast agents and detect signals from mi-
crobubbles in very slow flow without Doppler-related arti-
facts. It has recently been shown that this technique can
depict the typical enhancement patterns of three different
types of liver lesions: hemangiomas, metastases, and hepa-
tocellular carcinomas. While most hemangiomas (95%)
show peripheral globular or rim-like enhancement with
progressive centripetal fill-in, malignant tumors do not
show this pattern (9) (Fig. 12). Pulse-inversion harmonic
US with interval delay scanning using a contrast agent is
therefore believed to be potentially useful for the specific
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Fig. 9. A 51-year-old man with a hepatic hemangioma in the left lobe. 
A. Transverse US shows a slightly hyperchoic mass with a well-defined margin (arrow). 
B. Enhanced CT of the liver during the portal venous phase shows bright dot-like enhancement (arrow) in the periphery of the lesion. 
AB
Fig. 8. A 51-year-old man with a hepatic hemangioma in the right
lobe. Transverse US shows increased liver echogenicity, sugges-
tive of diffuse fatty infiltration, and an atypical echo-poor heman-
gioma. There is no discernable echogenic border.Spectrum of US Appearances of Hepatic Hemangiomas
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Fig. 10. A 55-year-old woman with a hepatic hemangioma in the right lobe. 
A. Sagittal US shows a well-defined hypoechoic mass (arrow). 
B. Enhanced CT scan of the liver obtained during the hepatic arterial phase shows diffuse rapid enhancement of the tumor (arrow) with
peritumoral wedge-shaped parenchymal enhancement (arrowheads), suggesting associated arterioportal shunt. 
AB
Fig. 11. A 54-year-old woman with a hepatic hemangioma in the
right lobe. 
A. Unenhanced power Doppler US shows a hypoechoic mass with
an echogenic border (arrows). The lesion shows minimal power
Doppler signal in its periphery (open arrow) and optimized parame-
ters (a pulse repetition frequency of 1,000 Hz and a medium wall
filter). 
B, C. Dynamic contrast-enhanced power Doppler US scans ob-
tained 30 seconds (B) and 90 seconds (C) after the initiation of
contrast injection show dot-like enhancement (small arrows) at the
periphery of the mass. However, unlike centripetal fill-in enhance-
ment, characteristic of hemangioma, the enhanced area revealed
by power Doppler US is smaller 90 seconds after enhancement
than at 30.  Even with the use of microbubble agents, power
Doppler US is, therefore, due to its insensitivity to slow flow, able to
characterize hepatic hemangiomas to only a limited extent.
A
C
Bdiagnosis of hepatic hemangiomas by demonstrating their
characteristic enhancement features. 
CONCLUSION
In the diagnosis of hepatic hemangiomas, the most im-
portant aspect is non-invasive differentiation from other
tumors. Since US plays a key role in the initial evaluation
of these hemangiomas, knowledge of the spectrum of those
that are atypical is important and can help avoid most di-
agnostic errors. At the same time, however, in most cases
of hemangioma with atypical sonographic features a specif-
ic diagnosis can be established by means of dynamic con-
trast-enhanced studies such as CT or MR imaging. Because
pulse-inversion harmonic US with interval delay scanning
using a contrast agent is also believed to be potentially use-
ful for the specific diagnosis of hepatic hemangiomas by
demonstrating their characteristic enhancement features,
simple and immediate characterization of a focal hepatic
lesion newly detected by initial US examination is possible. 
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Fig. 12. A 52-year-old man with two he-
patic hemangiomas in the left lobe. 
A. Pulse-inversion harmonic US scans
obtained prior to contrast injection show
a hypoechogenic hepatic hemangioma
(arrow) in the medial segment of the left
lobe. Serial contrast-enhanced US scans
obtained 14, 62, and 139 seconds after
injection show peripheral globular en-
hancement with progressive centripetal
fill-in (arrowheads). 
B. Serial dynamic contrast-enhanced T1-
weighted MR images obtained immedi-
ately, 60, and 180 seconds after the ad-
ministration of gadolinium-DTPA depict
early peripheral nodular and globular en-
hancement with progressive centripetal
fill-in (arrowheads), characteristic of he-
patic hemangiomas. The enhanced ar-
eas seen on MR images are nearly iden-
tical to those seen on serial contrast-en-
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